S1P4 receptor mediates S1P-Induced vasoconstriction in normotensive and hypertensive rat lungs

Pulmonary Circulation

Volumn 1, Issue 3, 2011, Pages 399-404

  Ota, Hiroki ^a   Beutz, Michelle A ^b   Ito, Masako ^a   Abe, Kohtaro ^a   Oka, Masahiko ^a   McMurtry, Ivan F ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Pulmonary arteries; Pulmonary hypertension; S1P4 receptor; Sphingosine 1 phosphate

Indexed keywords

EID: 85016365810     PISSN: 20458932     EISSN: 20458940     Source Type: Journal    
DOI: 10.4103/2045-8932.87309     Document Type: Article

References (34)

1. Alewijnse AE, Peters SL. Sphingolipid signalling in the cardiovascular system: Good, bad or both? Eur J Pharmacol 2008;585:292-302.
2. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 2007;115:84-105.
3. Maceyka M, Milstien S, Spiegel S. Sphingosine-1-phosphate: The Swiss army knife of sphingolipid signaling. J Lipid Res 2009;50 Suppl:S272-6.
4. Rivera R, Chun J. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol 2008;160:25-46.
5. Skoura A, Hla T. Lysophospholipid receptors in vertebrate development, physiology, and pathology. J Lipid Res 2009;50 Suppl:S293-8.
6. Hemmings DG. Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. Naunyn Schmiedebergs Arch Pharmacol 2006;373:18-29.
7. Igarashi J, Michel T. Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res 2009;82:212-20.
8. Levkau B. Sphingosine-1-phosphate in the regulation of vascular tone: A finely tuned integration system of S1P sources, receptors, and vascular responsiveness. Circ Res 2008;103:231-3.
9. Skoura A, Hla T. Regulation of vascular physiology and pathology by the S1P2 receptor subtype. Cardiovasc Res 2009;82:221-8.
10. Uhlig S, Gulbins E. Sphingolipids in the lungs. Am J Respir Crit Care Med 2008;178:1100-14.
11. Thomas GD, Snetkov VA, Patel R, Leach RM, Aaronson PI, Ward JP. Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: Activation of non-store-operated Ca2+ entry. Cardiovasc Res 2005;68:56-64.
12. Hsiao SH, Constable PD, Smith GW, Haschek WM. Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings. Toxicol Sci 2005;86:194-9.
13. Szczepaniak WS, Pitt BR, McVerry BJ. S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. Am J Physiol Lung Cell Mol Physiol 2010:299:L137-45.
14. Wang L, Dudek SM. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 2009;77:39-45.
15. Nagaoka T, Morio Y, Casanova N, Bauer N, Gebb S, McMurtry I, et al. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 2004;287:L665-672.
16. Davis MD, Clemens JJ, Macdonald TL, Lynch KR. Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem 2005;280: 9833-41.
17. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, Ikeda H, et al. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 2003;58:170-7.
18. Candelore MR, Wright MJ, Tota LM, Milligan J, Shei GJ, Bergstrom JD, et al. Phytosphingosine 1-phosphate: A high affinity ligand for the S1P(4)/ Edg-6 receptor. Biochem Biophys Res Commun 2002;297:600-6.
19. Clemens JJ, Davis MD, Lynch KR, Macdonald TL. Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: Discovery of potent, subtype-selective S1P4 receptor agonists. Bioorg Med Chem Lett 2004;14:4903-6.
20. Muramatsu M, Tyler RC, Rodman DM, McMurtry IF. Possible role of T-type Ca2+ channels in L-NNA vasoconstriction of hypertensive rat lungs. Am J Physiol 1997;272:H2616-21.
21. Duckles SP, Carter BJ, Williams CL. Vascular adrenergic neuroeffector function does not decline in aged rats. Circ Res 1985;56:109-16.
22. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 2001;15:427-38.
23. Chang CL, Ho MC, Lee PH, Hsu CY, Huang WP, Lee H. S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. Am J Physiol Cell Physiol 2009;297:C451-8.
24. Watterson KR, Ratz PH, Spiegel S. The role of sphingosine-1-phosphate in smooth muscle contraction. Cell Signal 2005;17:289-98.
25. Graler MH, Bernhardt G, Lipp M. EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics 1998;53:164-9.
26. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, et al. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 2001;276:33697-704.
27. Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP, et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 2001;15:1212-4.
28. Graler MH, Grosse R, Kusch A, Kremmer E, Gudermann T, Lipp M. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J Cell Biochem 2003;89:507-19.
29. Sward K, Mita M, Wilson DP, Deng JT, Susnjar M, Walsh MP. The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep 2003;5:66-72.
30. Salomone S, Potts EM, Tyndall S, Ip PC, Chun J, Brinkmann V, et al. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 2008;153:140-7.
31. Salomone S, Waeber C. Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. Front Pharmacol 2011:2:9.
32. Broughton BR, Walker BR, Resta TC. Chronic hypoxia induces Rho kinasedependent myogenic tone in small pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 2008;294:L797-806.
33. Shimoda LA, Sham JS, Sylvester JT. Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res 2000;49:549-60.
34. Oldstone M, Hodder P, Crisp M, Roberts E, Guerrero M, Urbano M, et al. Probe Development Efforts to Identify Novel Antagonists of the Sphingosine 1-phosphate Receptor4 (S1P4). Probe Reports from the NIH Molecular Libraries Program [internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010